This brand name is authorized in Malta
The drug SEDOXIL contains one active pharmaceutical ingredient (API):
|
1
Mexazolam
UNII S5969B6237 - MEXAZOLAM
|
|
Mexazolam is a benzodiazepine indicated for the management of anxiety disorder associated or not to psychoneurotic conditions. The exact sites and mode of action have not been fully elucidated, but it appears to be mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), by the stimulation of specific receptors. Both GABA and chloride may enhance the binding to those receptors. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05BA | Benzodiazepine derivatives | N Nervous system → N05 Psycholeptics → N05B Anxiolytics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MT | Medicines Authority | Identifier(s): MA004/00201, PI242/01601A |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
